Project Details
Description
Protocol ML39356: AN OPEN-LABEL, MULTICENTER, EXPANDED ACCESS PROGRAM FOR EMICIZUMAB IN PATIENTS WITH HEMOPHILIA A WITH INHIBITORS
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/17 → 12/31/20 |
Funding
- GENENTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.